Home · Peptides · P21
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

P21

THE NEUROGENESIS BOOSTER

Neurotrophic Peptide P21; CNTF Analog

P21 is an engineered peptide based on ciliary neurotrophic factor (CNTF) that can cross the blood-brain barrier and promote neurogenesis, the growth of new brain cells. It boosts BDNF (brain-derived neurotrophic factor) and has shown promise for cognitive enhancement, Alzheimer's prevention, and stroke recovery.

P21
P21
P21

P21 Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About P21

◆

Is P21 FDA approved?

No. This profile records P21 as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for P21?

Dose: 10 mg daily (subcutaneous, intramuscular, or oral).

MORE CONTEXT ›

Schedule: daily. Cycle: 8 weeks on, 8 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this P21 guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Neurogenesis

Promotes growth of new neurons in the hippocampus

BDNF Boost

Upregulates brain-derived neurotrophic factor

Anti-Amyloid

Reduces amyloid-beta and tau pathology

Synaptic Plasticity

Enhances NMDA receptor activity for learning

Those concerned about cognitive decline
People wanting to enhance memory and focus
Those with family history of Alzheimer's
Stroke recovery patients

P21 Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.